Fujun Shi
Impact in
- Geriatrics and Gerontology top 5%
- Sirtuins and Resveratrol in Medicine
-
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
Papers in
-
- Sphingolipid Metabolism and Signaling 3
-
- Retinal Imaging and Analysis 1
- Co-authors
- Zong-hai Huang (4 shared papers)Robert Day (1 shared paper)Sophie Routhier (1 shared paper)Weijun Jin (1 shared paper)Xia Lei (1 shared paper)Debapriya Basu (1 shared paper)Chunyuan Liu (1 shared paper)Hongwei� Jiang (1 shared paper)
- Journals
- Journal of Neurotrauma (2 papers)Biomedicine & Pharmacotherapy (1 paper)BioMed Research International (1 paper)Journal of Cancer Research and Clinical Oncology (1 paper)World Journal of Surgical Oncology (1 paper)
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Fujun Shi
17 papers receiving 464 citations
Peers
Comparison fields: 5 of 61
- Geriatrics and Gerontology 50
- Cancer Research 111
- Cardiology and Cardiovascular Medicine 93
- Molecular Biology 214
- Cell Biology 48
Countries citing papers authored by Fujun Shi
This map shows the geographic impact of Fujun Shi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fujun Shi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fujun Shi more than expected).
Fields of papers citing papers by Fujun Shi
This network shows the impact of papers produced by Fujun Shi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fujun Shi. The network helps show where Fujun Shi may publish in the future.
Co-authors
The 25 scholars most cited alongside Fujun Shi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2011 | 117 | |
| 2 | 2019 | 68 | |
| 3 | 2016 | 67 | |
| 4 | 2010 | 65 | |
| 5 | 2014 | 61 | |
| 6 | 2021 | 30 | |
| 7 | 2013 | 17 | |
| 8 | 2009 | 16 | |
| 9 | 2017 | 6 | |
| 10 | 2018 | 6 | |
| 11 | 2024 | 5 | |
| 12 | 2024 | 3 | |
| 13 | [Screening molecular markers in early breast cancer of the same pathological types but with different prognoses using Agilent gene chip]. | 2013 | 3 |
| 14 | [Low dosage of homoharringtonine for prevention of cicatrization after glaucoma filtering surgery]. | 1995 | 3 |
| 15 | 2024 | 2 | |
| 16 | 2024 | 2 | |
| 17 | 2025 | 1 |
About Fujun Shi
Fujun Shi is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Cancer Research, Cellular and Molecular Neuroscience and Pulmonary and Respiratory Medicine, having authored 17 papers that have together received 472 indexed citations. Recurring topics across this work include Sphingolipid Metabolism and Signaling (3 papers), Neurogenesis and neuroplasticity mechanisms (2 papers), Nerve injury and regeneration (2 papers), MicroRNA in disease regulation (2 papers), Retinal Diseases and Treatments (1 paper), Retinal Imaging and Analysis (1 paper), Retinal and Optic Conditions (1 paper) and Ferroptosis and cancer prognosis (1 paper). The work is most often cited by research in Geriatrics and Gerontology (50 citations), Cancer Research (111 citations), Cardiology and Cardiovascular Medicine (93 citations), Molecular Biology (214 citations) and Cell Biology (48 citations). Fujun Shi has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Zong-hai Huang, Robert Day, Sophie Routhier, Weijun Jin, Xia Lei, Debapriya Basu, Chunyuan Liu, Hongwei� Jiang, Xian‐Cheng Jiang and Jinlong Yu. Their work appears in journals such as Journal of Neurotrauma, Biomedicine & Pharmacotherapy, BioMed Research International, Journal of Cancer Research and Clinical Oncology and World Journal of Surgical Oncology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.